|
MMACHC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.097620E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.607500E-04 |
| Normal-vs-Stage2 |
3.696200E-01 |
| Normal-vs-Stage3 |
6.16059999999363E-05 |
| Normal-vs-Stage4 |
1.66416999999308E-05 |
| Stage1-vs-Stage2 |
2.658000E-03 |
| Stage1-vs-Stage3 |
2.167200E-01 |
| Stage1-vs-Stage4 |
2.454000E-02 |
| Stage2-vs-Stage3 |
6.415900E-04 |
| Stage2-vs-Stage4 |
1.395720E-04 |
| Stage3-vs-Stage4 |
3.720800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85240000000397E-05 |
| Normal-vs-AfricanAmerican |
1.341650E-02 |
| Normal-vs-Asian |
2.960100E-03 |
| Caucasian-vs-AfricanAmerican |
9.100400E-01 |
| Caucasian-vs-Asian |
9.774600E-01 |
| AfricanAmerican-vs-Asian |
9.393000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.612500E-04 |
| Normal-vs-Female |
3.156600E-03 |
| Male-vs-Female |
2.089600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.165900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.166500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.291170E-01 |
| Normal-vs-Age(81-100Yrs) |
1.568970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.327200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.042970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.459600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.776000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.246200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.047800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.296200E-03 |
| Classical-VS-Follicular |
6.24409999999687E-05 |
| Classical-VS-Other |
3.978800E-01 |
| Classical-VS-Normal |
1.90538000000018E-05 |
| Tall-VS-Follicular |
1.39560000000927E-07 |
| Tall-VS-Other |
8.024800E-01 |
| Tall-VS-Normal |
4.01410000017144E-07 |
| Follicular-VS-Other |
7.760200E-02 |
| Follicular-VS-Normal |
7.052600E-01 |
| Other-VS-Normal |
2.732400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.880400E-02 |
| Normal-vs-N1 |
3.13740000645879E-09 |
| N0-vs-N1 |
9.34240018679589E-10 |
|
|
